«

»

Jun
03

Fosamax benefits bones in young CF patients

Young patients with cystic fibrosis and low bone mineral density (BMD) saw significant improvements in bone quality following a year on alendronate (Fosamax), an Italian multicenter study found. (Source: Medpage Today)